hc1.com, an Indianapolis, IN-based precision medicine startup, announced that existing investor Health Cloud Capital has exercised its option to provide additional growth funding, bringing the company’s total Series B capital raise to $10 million. Elevate Ventures also participated in the round. The additional capital will fund continued expansion of precision health initiatives underway at hc1, including solutions that combat the opioid crisis and optimize prescribing of other prescription
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Dicom Systems De-identifies 5.3 Million Radiology Exams
Dicom Systems, Inc., a leader in Enterprise Imaging IT, announced the completion of a large-scale de-identification project for Hospital for Special Surgery ("HSS") in New York, the global leader in musculoskeletal health and the leading orthopedic hospital in the U.S. The HSS Global Innovation Institute, which collaborates with industry, investors, and entrepreneurs to commercialize their portfolio of technologies, has partnered with an AI company to develop algorithms targeted to address the
Read More
RDMD Lands $3M to Drive Patient-Accelerated Drug Development in Rare Diseases
San Francisco-based RDMD, a biopharma startup dedicated to accelerating research for patients with rare diseases, announced its $3 million seed financing backed by Lux Capital and Village Global, whose network of backers include Bill Gates, Mark Zuckerberg, Jeff Bezos, and Reid Hoffman. RDMD has developed a technology platform that generates deep data insights to accelerate rare disease research and drug development, as well as a patient application that empowers patients and families to get
Read More
Urology Startup Urotronic Raises $20M to Expand Innovative Optilume Device
Plymouth based Urotronic, today announced it has raised $20 million in Series B funding led by HM (Hillhouse & Mayo Clinic) Ventures. Additional investments were made by CDBI Partners, OCXPROURO Limited andLegend Capital. The investments will support the growth of the innovative device called Optilume which combines balloon dilation with the delivery of an anti-proliferative drug to inhibit recurrence of blockages in the urinary tract.A minimally invasive urethral stricture treatment, the
Read More
Fitbit Unveils Charge 3 with Relative SpO2 Sensor, Launches Sleep Score Beta
Wearable leader Fitbit, today announced the unveiling of Fitbit Charge 3, the latest evolution of its best-selling Charge family of devices. Fitbit Charge 3 features an elevated, premium swim-proof design with a touchscreen display, 15+ goal-based exercise modes, essential smart features to stay connected to what matters most, up to 7 days of battery life, and Fitbit’s most advanced sensor and algorithm technology in a tracker. Charge 3 is available for presale today on Fitbit.com for $149.95,
Read More
Why The Retailization of Healthcare Begins with Women
The face of consumerism is rapidly changing in the age of technology. Convenience, personalization, and long-term benefits are of paramount concern to developers as consumers increasingly prioritize experience over possessions. The five-star rating format and other consumer-friendly features of sites like Amazon, Yelp, and TripAdvisor have been shaping consumer behavior and expectations for more than a decade. Direct-to-consumer brands like BirchBox, ThirdLove, and StitchFix are revolutionizing
Read More
Bullshit Metrics: Is Patient Engagement Real?
Whether it’s stock trading with a few clicks on a smartphone, streaming new music before the vinyl hit the shelves, or receiving a wardrobe from a personal stylist without ever stepping into a store, technology’s potential to revolutionize the consumer experience is ubiquitous across industries. The healthcare sphere is no exception to this, and in recent years a rash of digital health tools and connected devices have flooded the marketplace, promising cheaper care and better outcomes, all while
Read More
Akouos Raises $50M to Advance Precision Medicine for Hearing Disorders
Akouos, a Boston, MA-based precision genetic medicine company developing gene therapies that restore and preserve hearing has raised $50 million in Series A funding co-led by 5AM Ventures and New Enterprise Associates (NEA) with participation from existing investor Partners Innovation Fund and new investors Sofinnova Ventures, RA Capital Management and Novartis Venture Fund. The company plans to use the funding round to advance its lead program to first-in-human clinical trials and bolster its
Read More
Trilliant Health Lands $12M for Intelligent Patient Acquisition Platform
Trilliant Health, a Nashville, TN.-based healthcare analytics company that empowers intelligence patient acquisition has raised $12 million in Series A funding led by Noro-Moseley Partners, with participation from existing investors Martin Ventures, Nashville Capital Network, and NueCura Partners. Trilliant Health plans to use the funding to continue building its data science and technology teams to enhance the capabilities of its analytics platformFounded by 2017, Trilliant provides an
Read More
Mount Sinai Researchers Create RNA and DNA-Sequencing Platform to Find Effective Therapies for Blood Cancer Patients
Mount Sinai researches have finished the first ever clinical trial using RNA-sequencing-based drug repurposing to find effective therapies for multiple myeloma patients (potentially for any cancer). Dr. Samir Parekh and his genomics and precision health colleagues at Mount Sinai created this first-ever trial to better inform the way patient’s therapies are chosen. The trial involved 64 patients who had run out of treatment options and many of whom had been referred to hospice. The trial
Read More
